Approval · Notice of Compliance 1713 · 2003
ARAVA: Notice of Compliance 1713
Issued May 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1713
- Date
- May 14, 2003
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update: revisions to the clinical pharmacology section
- Therapeutic class
- Antirheumatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARAVA | Not yet assigned | — |
Medicinal ingredients
- LEFLUNOMIDE 10 MG per TAB
- LEFLUNOMIDE 20 MG per TAB
- LEFLUNOMIDE 100 MG per TAB